A Purified Recombinant Lipopeptide as Adjuvant for Cancer Immunotherapy
Figure 6
Anti-tumor effects of Pam3CSK4. TC-1 tumor-bearing mice (5 or 6 animals/group) received a single injection of PBS or 10 μg of RAH mixed with Pam3CSK4 (10 μg/100 μL). The tumor diameters are shown (cm3).
